KSP

Mira Robotics is a software based company provide services that can robots in various fields.

Melody International is a manufacturing company that develops and offers medical equipment for remote medical services.

Metcela is a clinical-stage biotech startup providing patients with an innovative and alternative treatment option for heart disease. The company's lead asset, MTC001 is a cell therapy based on VCAM-1-positive Cardiac Fibroblast (VCF) that re-established a favorable microenvironment and repaired damaged heart tissues in preclinical studies. Metcela's therapy uses a specific fibroblast cell that is obtained from the patient's heart and instead of replacing them, it repairs the damage by enhancing the cells' ability to heal, providing patients with an effective and reasonably-priced cure for heart failure. It was founded on March 9, 2016, and is headquartered in Kawasaki, Japan.

AdipoSeeds, though a novel technology, creates platelets from mesenchymal stem cells without a complex and costly gene transfer. It aims to invent new blood supply system to solve the shortage of platelets in the world, and to create a future where a platelet-related treatment will be cheaply and safely provided.

Luxonus is a medical device manufacturing company that offers new imaging device with optical ultrasonic technology.

Ampametry provides neuropsychiatric drugs with AMPA-PET technology. They offers central nervous system drug discovery business AMPA-PET technology.

IGS investigates theories and methods for visualizing object internal structures. The company is developing, manufacturing, and selling the world's highest performance measurement system based on Dr. Kimura's and others' multi-path scattered field theory, which is known as an unsolved problem in the history of applied mathematics.

iXs is a start-up to solve social problems with robot technology.In addition to the development of inspection / business robots and special environment-compatible robots that we have been conducting so far, we have developed and operated AI / Data Service systems and analyzed big data. We provide products and services. We provide consistent support from introduction to operation of products and services that can be used and used, to solve customer issues.

IGS investigates theories and methods for visualizing object internal structures. The company is developing, manufacturing, and selling the world's highest performance measurement system based on Dr. Kimura's and others' multi-path scattered field theory, which is known as an unsolved problem in the history of applied mathematics.

Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.

Miraikikai is a start-up originating from Kagawa University with a mission to create intelligent mobile robots for professional-use.Their robots products, designed based on field reseach to provide the high quality and the best cost effective solution, are achieved with mechanical design and control technology backed by the latest research achievements and years of experience.

Metcela is a clinical-stage biotech startup providing patients with an innovative and alternative treatment option for heart disease. The company's lead asset, MTC001 is a cell therapy based on VCAM-1-positive Cardiac Fibroblast (VCF) that re-established a favorable microenvironment and repaired damaged heart tissues in preclinical studies. Metcela's therapy uses a specific fibroblast cell that is obtained from the patient's heart and instead of replacing them, it repairs the damage by enhancing the cells' ability to heal, providing patients with an effective and reasonably-priced cure for heart failure. It was founded on March 9, 2016, and is headquartered in Kawasaki, Japan.

Renascience is a research and development firm that creates treatments to solve medical issues and manufactures pharmaceuticals.

Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally. The company offers 3D BioFabrication systems and related consumables; develops and licenses 3D tissue products for therapeutic and drug development use; and engages in contract manufacturing of 3D tissue products for research purposes. Its products applications include blood vessel grafts for blood access of hemodialysis patients or coronary artery bypass grafts; cardiac grafts for drug toxicology screening or supplemental therapy of myocardial infarction; cartilage grafts for plastic surgery or reconstruction; and hepatocyte grafts for drug metabolism screening or in-vivo production of clotting factors in the treatment of hemophilia. Cyfuse Biomedical was founded in 2010 and is based in Tokyo, Japan.

Stem Rim is a biotechnology company aiming to develop “regenerative medicine”.We are developing drugs based on a new mechanism of action that mobilizes stem cells present in the living body to the injured or diseased tissue without removing them out of the body and induces functional tissue regeneration.

CODE Meee is a comprehensive scent company. They also provide optimal scents based on data to individuals and companies. Additionally, they also provide fragrant product planning and manufacturing services.

In the pharmaceutical market, attention has been focused on nucleic acid drugs to meet unmet medical needs such as cancer and intractable diseases.This is because nucleic acid drugs have the following advantages.It is possible to target intracellular drug molecules that could not be targeted by conventional drugsDrug discovery research is possible for any gene as long as there is technology to deliver nucleic acids to the expression siteMore specific than low molecular weight compounds and less susceptible to side effects Unlike antibody drugs, nucleic acid drugs can be manufactured by chemical synthesis at a relatively low cost.

Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.

"Z-Works Life Engine" is a cloud-type IoT platform. Collect and analyze the data of the terminal equipped with Z-Wave on the cloud, you can browse various data with the smartphone and remotely control the terminal equipped with Z-Wave.

Spectronics is a development of new technologies and new applications to bring about innovation, focusing on the future of laser technology.

Kringle Pharma, Inc. is a biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF) protein medicines and NK4 molecules. Established in 2001 and headquartered in Japan, the company aims to harness the regenerative properties of HGF for various medical conditions, including acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scarring. In addition to HGF, Kringle Pharma develops NK4, which acts as an antagonist to HGF and exhibits anti-cancer properties by inhibiting tumor cell invasion and metastasis. The company's product pipeline includes recombinant human HGF for treating acute renal failure, skin ulcers, and central nervous system disorders, as well as NK4 and NK4 gene therapies for cancer treatment.

Starsphere offers the “Everywhere Forms EDC” cloud service with the philosophy of constantly changing the way data is collected, analyzed and used in life sciences. Starsphere vision is to deliver safer and more efficient treatments to those who need them faster.

Stem Cell & Device Laboratory is aiming to contribute to a healthy society with new cell application products.

Ipoca is a digital solution business for retail and distribution companies. It offers an in-store information platform for real stores. Ipoca contributes to the revitalization of the local economy and the Japanese economy by encouraging the mobility of people by discovering the charm of the town. The company was established in 2007 and is headquartered in Tokyo, Japan.

Nanoegg is aiming to create a medical breakthrough from skin research and to realize medical care without the use of needles.

Fileforce provides highly secure and scalable cloud file service for businesses and enterprises of all sizes. Fileforce enables your enterprise to safely and securely store, manage, access and share files from anywhere, using computer, tablet or smartphone.

TMS is a Tokyo-based clinical-stage biotech company that unlocks fungus-derived SMTP small molecule compound group. SMTPs have novel dual mode of action, both thrombolytic and anti-inflammatory. The lead compound TMS-007 is in Phase IIa clinical trial indicated for acute ischemic stroke and partnered with Biogen.

In the pharmaceutical market, attention has been focused on nucleic acid drugs to meet unmet medical needs such as cancer and intractable diseases.This is because nucleic acid drugs have the following advantages.It is possible to target intracellular drug molecules that could not be targeted by conventional drugsDrug discovery research is possible for any gene as long as there is technology to deliver nucleic acids to the expression siteMore specific than low molecular weight compounds and less susceptible to side effects Unlike antibody drugs, nucleic acid drugs can be manufactured by chemical synthesis at a relatively low cost.

Megakaryon is a medical research company that develops and sells blood products.

BrightPath Biotherapeutics is a stage biopharmaceutical company focused on developing novel cancer immunotherapies. The company develops products based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens.

REGiMMUNE Corporation is a private biopharmaceutical company developing innovative solutions for treating immune disorders caused by nonspecific and/or excessive immune reactions. REGiMMUNE uses its proprietary technology platform, reVax (reverse vaccination), to target immune tolerance against specific disease-causing antigens through induction of regulatory T cells (Treg). This technology has potential applications in a number of immune system disorders and diseases including Graft versus Host Disease (GvHD), type 1 diabetes mellitus (T1DM), rheumatoid arthritis (RA), multiple sclerosis (MS) and systemic lupus erythematosus (SLE). Currently, the company has one clinical-stage compound in a Phase I/II trial in the United States (RGI-2001) as a treatment for GvHD associated with hematopoietic stem cell transplantation and has a second product in preclinical development (RGI-3001) as a new treatment for T1DM. In addition, it has a number of well-differentiated compounds in its research-stage pipeline. In healthy individuals, the normal immune system works to protect humans from disease-causing viruses, bacterium, and cancers; or foreign antigens such as peanuts, wheat and tree pollens. Conventional immunosuppressants have several significant side effects associated with long-term administration including risk of infection, toxicity and relapse. Products developed with ReVax technology are expected to reduce or eliminate such side effects as well as reduce long-term treatment.

Ipoca is a digital solution business for retail and distribution companies. It offers an in-store information platform for real stores. Ipoca contributes to the revitalization of the local economy and the Japanese economy by encouraging the mobility of people by discovering the charm of the town. The company was established in 2007 and is headquartered in Tokyo, Japan.

Connectec Japan develops semiconductor chip bonding, low-temperature MEMS chips, small desktop semiconductor assembly equipment, and device bonding on low-heat-resistant substrates and facilitates the development of prototypes.